In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Danaher agrees to acquire Pall

Executive Summary

Danaher Corp. acquired publicly traded Pall Corp. (global filtration and purification solutions) for $13.8bn in cash including assumed debt and net of acquired cash. The offer is for $127.20 per share in cash (a 27% premium). Upon closing of the transaction, Danaher will split into two publicly listed companies - a science and technology-focused company including the Pall businesses (retaining the Danaher name), and a new more industrial-focused entity.
Deal Industry
  • Medical Devices
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies